Frontier Capital Management CO LLC Clovis Oncology, Inc. Transaction History

Frontier Capital Management CO LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 30, 2018	SELL	$50.12 - $67.72 $2.17 Million - $2.93 Million	-43,276 Closed	0 $0
Q4 2017 Jan 18, 2018	SELL	$57.69 - $84.58 $8.64 Million - $12.7 Million	-149,715 Reduced 77.58%	43,276 $2.94 Million
Q3 2017 Oct 31, 2017	BUY	$67.17 - $84.81 $13 Million - $16.4 Million	192,991	192,991 $15.9 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.